Continuous glucose monitors, or CGMs, were developed for use by diabetes patients but their makers, led by Abbott (ABT.N) and Dexcom (DXCM.O), also spy opportunities in sports and wellness. Diabetes patients remain the CGM specialist’s commercial focus, he told Reuters, but Dexcom is also working with researchers on future use to optimize athletic performance. Top athletes and their support staff have been using CGMs to optimize calorie intake and workout intensity as they prepare for sport events. Other market researchers estimate the overall CGM market including diabetic use, with suppliers like Medtronic (MDT.N), will grow 9-10% annually over five years. Larsen warned, however, that there was little validated science yet on how to optimize an athlete’s routines using CGMs.

Source: CNN June 10, 2024 19:26 UTC